Journal of Cardiac Failure

Article	Citations
Universal Definition and Classification of Heart Failure	358
Elevated Troponin in Patients With Coronavirus Disease 2019: Possible Mechanisms	223
2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure	159
Joint HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19	142
Virtual Visits for Care of Patients with Heart Failure in the Era of COVID-19: A Statement from the Heart Failure Society of America	136
Reductions in Heart Failure Hospitalizations During the COVID-19 Pandemic	84
Electrocardiographic Findings in Coronavirus Disease-19: Insights on Mortality and Underlying Myocardial Processes	76
JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure	63
Sex Differences in Heart Failure	61
Stabilization of Cardiac Function With Diflunisal in Transthyretin (ATTR) Cardiac Amyloidosis	59
Uric Acid Is a Biomarker of Oxidative Stress in the Failing Heart: Lessons Learned from Trials With Allopurinol and SGLT2 Inhibitors	53
Effects of Elamipretide on Left Ventricular Function in Patients With Heart Failure With Reduced Ejection Fraction: The PROGRESS-HF Phase 2 Trial	50
Heart Failure-Related Cardiogenic Shock: Pathophysiology, Evaluation and Management Considerations	49
Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America	48
2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure: Executive Summary	48
The Impact of the Coronavirus Disease-2019 Pandemic and Italian Lockdown Measures on Clinical Presentation and Management of Acute Heart Failure	48
Metabolomic Profile in HFpEF vs HFrEF Patients	46
Economic Issues in Heart Failure in the United States	44
Trends in Heart Failure Hospitalizations in the US from 2008 to 2018	43
De Novo vs Acute-on-Chronic Presentations of Heart Failure-Related Cardiogenic Shock: Insights from the Critical Care Cardiology Trials Network Registry	39
Racial and Ethnic Disparities Persist in the Current Era of Pediatric Heart Transplantation	37
Coronavirus Disease-2019 in Heart Transplant Recipients in Southeastern Michigan: A Case Series	37
Myocardial Ketones Metabolism in Heart Failure	36
Hemodynamics for the Heart Failure Clinician: A State-of-the-Art Review	35
Right Ventricular Dysfunction Is Common and Identifies Patients at Risk of Dying in Cardiogenic Shock	34

Vagus Nerve Stimulation Provides Multiyear Improvements in Autonomic Function and Cardiac Electrical Stability in the ANTHEM-HF Study	32
Sacubitril/Valsartan Initiation and Postdischarge Adherence Among Patients Hospitalized for Heart Failure	31
Sarcoidosis-Related Cardiomyopathy: Current Knowledge, Challenges, and Future Perspectives State-of-the-Art Review	31
Association of Coronary Microvascular Dysfunction With Heart Failure Hospitalizations and Mortality in Heart Failure With Preserved Ejection Fraction: A Follow-up in the PROMIS-HFpEF Study	30
Clinical and Imaging Response to Tumor Necrosis Factor Alpha Inhibitors in Treatment of Cardiac Sarcoidosis: A Multicenter Experience	29
The Effect of Decongestion on Intrarenal Venous Flow Patterns in Patients With Acute Heart Failure	29
Lactate Clearance Is Associated With Improved Survival in Cardiogenic Shock: A Systematic Review and Meta-Analysis of Prognostic Factor Studies	29
Effects of Depression on Heart Failure Self-Care	28
Arterial Stiffness and Vascular Load in HFpEF: Differences Among Women and Men	28
Prognostic Impact of Changes in Intrarenal Venous Flow Pattern in Patients With Heart Failure	27
Clinically Suspected Myocarditis in the Course of Severe Acute Respiratory Syndrome Novel Coronavirus-2 Infection: Fact or Fiction?	27
Heart Failure Association, Heart Failure Society of America, and Japanese Heart Failure Society Position Statement on Endomyocardial Biopsy	27
Misdiagnosis of Heart Failure: A Systematic Review of the Literature	26
A Clinician's Guide to the 2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure	26
Sacubitril/Valsartan Therapy Ameliorates Ventricular Tachyarrhythmia Inducibility in a Rabbit Myocardial Infarction Model	26
Risk Prediction in Cardiogenic Shock: Current State of Knowledge, Challenges and Opportunities	26
Novel Coronavirus Disease 2019 in a Patient on Durable Left Ventricular Assist Device Support	25
Impact of a Formal Advance Care Planning Program on End-of-Life Care for Patients With Heart Failure: Results From a Randomized Controlled Trial	25
Medical Therapy During Hospitalization for Heart Failure With Reduced Ejection Fraction: The VICTORIA Registry	24
Multiple cArdiac seNsors for mAnaGEment of Heart Failure (MANAGE-HF) – Phase I Evaluation of the Integration and Safety of the HeartLogic Multisensor Algorithm in Patients With Heart Failure	24
Understanding Longitudinal Changes in Pulmonary Vascular Resistance After Left Ventricular Assist Device Implantation	24
Diastolic Dysfunction in Patients With Human Immunodeficiency Virus Receiving Antiretroviral Therapy: Results From the CHART Study	24
Beneficial Effects of Listening to Classical Music in Patients With Heart Failure: A Randomized Controlled Trial	23
The Role of Cardiac Rehabilitation in Reducing Major Adverse Cardiac Events in Heart Transplant Patients	22
Cognition, Physical Function, and Quality of Life in Older Patients With Acute Decompensated Heart Failure	22
Discordance of Pressure and Volume: Potential Implications for Pressure-Guided Remote Monitoring in Heart Failure	21
Enhancing ICD-Code-Based Case Definition for Heart Failure Using Electronic Medical Record Data	21
Management of Cardiac Sarcoidosis Using Mycophenolate Mofetil as a Steroid-Sparing Agent	21
Impact of Right Atrial Remodeling in Heart Failure With Preserved Ejection Fraction	21
Practices of Referring Patients to Advanced Heart Failure Centers	21
The V-LAP System for Remote Left Atrial Pressure Monitoring of Patients With Heart Failure	21
Aortic Insufficiency During HeartMate 3 Left Ventricular Assist Device Support	21
Prominent Longitudinal Strain Reduction of Basal Left Ventricular Segments in Patients With Coronavirus Disease-19	21
Ranolazine Improves Right Ventricular Function in Patients With Precapillary Pulmonary Hypertension: Results From a Double-Blind, Randomized, Placebo-Controlled Trial	21
Self-care Management Intervention in Heart Failure (SMART-HF): A Multicenter Randomized Controlled Trial	21
Wearable Patch-Based Estimation of Oxygen Uptake and Assessment of Clinical Status during Cardiopulmonary Exercise Testing in Patients With Heart Failure	20
Association Between β-Blockers and Outcomes in Heart Failure With Preserved Ejection Fraction: Current Insights From the SwedeHF Registry	20
Generalizability of HFA-PEFF and H2FPEF Diagnostic Algorithms and Associations With Heart Failure Indices and Proteomic Biomarkers: Insights From PROMIS-HFpEF	20
Heart Failure in the COVID-19 Pandemic: Where Has All New York's Congestion Gone?	20
Assessment of Myocardial Fibrosis Using Two-Dimensional and Three-Dimensional Speckle Tracking Echocardiography in Dilated Cardiomyopathy With Advanced Heart Failure	19
Sex Differences in the Phenotype of Transthyretin Cardiac Amyloidosis Due to Val122Ile Mutation: Insights from Noninvasive Pressure–Volume Analysis	19
Comparative Effectiveness of Dosing of Medical Therapy for Heart Failure: From the CHAMP-HF Registry	19
Eligibility for Dapagliflozin and Empagliflozin in a Real-world Heart Failure Population	19
Cognitive Decline and Risk of Dementia in Individuals With Heart Failure: A Systematic Review and Meta-analysis	19
Pregnancy after Heart Transplantation	19
Donation After Circulatory Death in Heart Transplantation: History, Outcomes, Clinical Challenges, and Opportunities to Expand the Donor Pool	18
Changes in Care Delivery for Patients With Heart Failure During the COVID-19 Pandemic: Results of a Multicenter Survey	18
High-Choline Diet Exacerbates Cardiac Dysfunction, Fibrosis, and Inflammation in a Mouse Model of Heart Failure With Preserved Ejection Fraction	18
H2FPEF Score Reflects the Left Atrial Strain and Predicts Prognosis in Patients With Heart Failure With Preserved Ejection Fraction	18
The Association Between Socioeconomic Status, Sex, Race / Ethnicity and In-Hospital Mortality Among Patients Hospitalized for Heart Failure	18

The Dietary Approaches to Stop Hypertension (DASH) Diet Pattern and Incident Heart Failure	18
The Impact of Health Care Disparities on Patients With Heart Failure	18
Iron Deficiency Is Associated With Impaired Biventricular Reserve and Reduced Exercise Capacity in Patients With Unexplained Dyspnea	18
Dynamic Assessment of Pulmonary Artery Pulsatility Index Provides Incremental Risk Assessment for Early Right Ventricular Failure After Left Ventricular Assist Device	18
Rationale and Design of the Proactive-HF Trial for Managing Patients With NYHA Class III Heart Failure by Using the Combined Cordella Pulmonary Artery Sensor and the Cordella Heart Failure System	18
Iron Deficiency in Heart Failure: A Scientific Statement from the Heart Failure Society of America	17
Prevalence of Left Ventricular Systolic Dysfunction in Myotonic Dystrophy Type 1: A Systematic Review	17
Dual Vasopressin Receptor Antagonism to Improve Congestion in Patients With Acute Heart Failure: Design of the AVANTI Trial	17
Interleukin-6 and Outcomes in Acute Heart Failure: An ASCEND-HF Substudy	16
Unique Patterns of Cardiovascular Involvement in Coronavirus Disease-2019	16
Building a Heart Failure Clinic: A Practical Guide from the Heart Failure Society of America	16
Rituximab for the Treatment of Refractory Cardiac Sarcoidosis: A Single-Center Experience	16
Predicting 30-Day Readmissions in Patients With Heart Failure Using Administrative Data: A Machine Learning Approach	16
Combined Heart-Kidney Transplant Versus Sequential Kidney Transplant in Heart Transplant Recipients	15
Empagliflozin in Heart Failure With Predicted Preserved Versus Reduced Ejection Fraction: Data From the EMPA-REG OUTCOME Trial	15
Socioeconomic Deprivation and Heart Failure Mortality in the United States	15
Left Ventricular Assist Devices at the Crossroad of Innovation in Advanced Heart Failure	15
Intestinal Flora Dysbiosis Aggravates Cognitive Dysfunction Associated With Neuroinflammation in Heart Failure	15
In-Hospital Management of Sleep Apnea During Heart Failure Hospitalization: A Randomized Controlled Trial	15
Possible Association Between Body Temperature and B-Type Natriuretic Peptide in Patients With Cardiovascular Diseases	15
Acute Unloading Effects of Sildenafil Enhance Right Ventricular–Pulmonary Artery Coupling in Heart Failure	15
Prognostic Significance of an Early Echocardiographic Evaluation of Right Ventricular Dimension and Function in Acute Heart Failure	15
Long-term Risk of Death and Hospitalization in Patients With Heart Failure and Takotsubo Syndrome: Insights From a Nationwide Cohort	14
The Potential Roles of Osmotic and Nonosmotic Sodium Handling in Mediating the Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Heart Failure	14
Vasoplegia Following Orthotopic Heart Transplantation: Prevalence, Predictors and Clinical Outcomes	14
Changes in Stressed Blood Volume with Levosimendan in Pulmonary Hypertension from Heart Failure with Preserved Ejection Fraction: Insights Regarding Mechanism of Action From the HELP Trial	14
Enhanced Echo Intensity of Skeletal Muscle Is Associated With Exercise Intolerance in Patients With Heart Failure	14
Cultivating Interest in Heart Failure Careers: Can We Reverse the Current Trend?	14
Association between Respiratory Failure and Clinical Outcomes in Patients with Acute Heart Failure: Analysis of 5 Pooled Clinical Trials	14
Lung Ultrasound for Heart Failure Diagnosis in Primary Care	14
Resting Heart Rate as an Important Predictor of Mortality and Morbidity in Ambulatory Patients With Heart Failure: A Systematic Review and Meta-Analysis	14
Short-term Outcomes in Ambulatory Heart Failure during the COVID-19 Pandemic: Insights from Pulmonary Artery Pressure Monitoring	14
Diuresis-Related Weight Loss Reflects Interstitial Compartment Decongestion with Minimal Impact on Intravascular Volume Expansion or Outcomes in Post-Acute Heart Failure	14
Coronavirus Disease-2019 and Heart Failure: A Scientific Statement From the Heart Failure Society of America	14
Representativeness of the VICTORIA Trial Population in Clinical Practice: Analysis of the PINNACLE Registry	14
Sustained Reduction in Pulmonary Artery Pressures and Hospitalizations During 2 Years of Ambulatory Monitoring	14
Characteristics of Elderly Patients with Heart Failure and Impact on Activities of Daily Living: A Registry Report from Super-Aged Society	14
Pregnancy Associated Heart Failure With Preserved Ejection Fraction: Risk Factors and Maternal Morbidity	14
Influence of Donor Transmitted and Rapidly Progressive Coronary Vascular Disease on Long-Term Outcomes After Heart Transplantation: A Contemporary Intravascular Ultrasound Analysis	13
Temporal Trends in Post Myocardial Infarction Heart Failure and Outcomes Among Older Adults	13
Risk of Hospitalization for Heart Failure in Patients With Hyperkalemia Treated With Sodium Zirconium Cyclosilicate Versus Patiromer	13
Associations of Angiopoietins With Heart Failure Incidence and Severity	13
Epidemiology, Pathophysiology, Diagnosis, and Therapy of Heart Failure With Preserved Ejection Fraction in Japan	13
Center Variability in Patient Outcomes Following HeartMate 3 Implantation: An Analysis of the MOMENTUM 3 Trial	13
Biomarkers and Their Relation to Cardiac Function Late After Peripartum Cardiomyopathy	13
Pulmonary Artery Catheter Use and Risk of In-hospital Death in Heart Failure Cardiogenic Shock	13
Right Ventricular Pressure–Volume Analysis During Left Ventricular Assist Device Speed Optimization Studies: Insights Into Interventricular Interactions and Right Ventricular Failure	13
Drugs of Abuse and Heart Failure	13
Impact of the Coronavirus Disease-19 Outbreak on Physical Activity of Patients With Implantable Cardioverter Defibrillators	13
Utility of the Nutritional Screening in Predicting Adverse Outcome of Patients With Overweight/Obesity and Acute Heart Failure	12
Characteristics and Outcomes of Patients With a Left Ventricular Assist Device With Coronavirus Disease-19	12
Estimation of Stressed Blood Volume in Patients With Cardiogenic Shock From Acute Myocardial Infarction and Decompensated Heart Failure	12
Bioimpedance Indices of Fluid Overload and Cardiorenal Outcomes in Heart Failure and Chronic Kidney Disease: a Systematic Review	12
Impact of Mental Stress and Anger on Indices of Diastolic Function in Patients With Heart Failure	12
Multidisciplinary Care in Heart Failure Services	12
Atrial Fibrillation, Thromboembolic Risk, and Anticoagulation in Cardiac Amyloidosis: A Review	12
Relationship Between Soluble Transferrin Receptor and Clinical Outcomes in Patients With Heart Failure According to Ejection Fraction Phenotype: The New Zealand PEOPLE Study	12
Physiology and Clinical Utility of HeartMate Pump Parameters	12
Longitudinal Trajectories of Hemodynamics Following Left Ventricular Assist Device Implantation	12
Ambulatory Treatment of Worsening Heart Failure With Intravenous Loop Diuretics: A Four-Year Experience	12
Increased Opportunities for Transplantation for Women in the New Heart Allocation System	12
Fatigue in Persons With Heart Failure: A Systematic Literature Review and Meta-Synthesis Using the Biopsychosocial Model of Health	12
The Road Not Yet Traveled: Distinction in Critical Care Cardiology through the Advanced Heart Failure and Transplant Cardiology Training Pathway	12
Acute Hemodynamic Effects of Sacubitril-Valsartan In Heart Failure Patients Receiving Intravenous Vasodilator and Inotropic Therapy	12
Soluble CD14 and Risk of Heart Failure and Its Subtypes in Older Adults	12
Cystatin C and Muscle Mass in Patients With Heart Failure	11
A Roadmap to Reinvigorating Training Pathways Focused on the Care of Patients With Heart Failure: Shifting From Failure to Function	11
Pharmacist- and Nurse-Led Medical Optimization in Heart Failure: A Systematic Review and Meta-Analysis	11
Contemporary Use of Venoarterial Extracorporeal Membrane Oxygenation: Insights from the Multicenter RESCUE Registry	11
The International Society for Heart and Lung Transplantation/Heart Failure Society of America Guideline on Acute Mechanical Circulatory Support	11
The ACTN3 577XX Null Genotype Is Associated with Low Left Ventricular Dilation-Free Survival Rate in Patients with Duchenne Muscular Dystrophy	11
Phenotype/Genotype Relationship in Left Ventricular Noncompaction: Ion Channel Gene Mutations Are Associated With Preserved Left Ventricular Systolic Function and Biventricular Noncompaction	11
Transition to Advanced Therapies in Elderly Patients Supported by Extracorporeal Membrane Oxygenation Therapy	11
Patient-centered Outcomes in HFrEF Following a Worsening Heart Failure Event: A Survey Analysis	11
Aortic Pulsatility Index: A Novel Hemodynamic Variable for Evaluation of Decompensated Heart Failure	11
Bariatric Surgery in Patients with Obesity and Ventricular Assist Devices Considered for Heart Transplantation: Systematic Review and Individual Participant Data Meta-analysis	11
Potential Utility of Cardiorenal Biomarkers for Prediction and Prognostication of Worsening Renal Function in Acute Heart Failure	11
Waitlist Outcomes for Children With Congenital Heart Disease: Lessons Learned From Over 5000 Heart Transplant Listings in the United States	11
Increased Red Cell Volume Is a Relevant Contributing Factor to an Expanded Blood Volume in Compensated Systolic Chronic Heart Failure	11
Hospitalization for Heart Failure in the United States, UK, Taiwan, and Japan: An International Comparison of Administrative Health Records on 413,385 Individual Patients	11

Exercise Intolerance in Heart Failure With Preserved Ejection Fraction: Arterial Stiffness and Abnormal Left Ventricular Hemodynamic Responses During Exercise	11
TRPM4 Modulates Right Ventricular Remodeling Under Pressure Load Accompanied With Decreased Expression Level	11
Prognostic Understanding and Preference for the Communication Process with Physicians in Hospitalized Heart Failure Patients	11
PCSK9 Inhibitors in Heart Transplant Patients: Safety, Efficacy, and Angiographic Correlates	11
Comparison of Soluble ST2, Pentraxin-3, Galectin-3, and High-Sensitivity Troponin T of Cardiovascular Outcomes in Patients With Acute Decompensated Heart Failure	11
Increased Risk of Heart Failure Hospitalization With GLP-1 Receptor Agonists in Patients With Reduced Ejection Fraction: A Meta-Analysis of the EXSCEL and FIGHT Trials	11
EXPANDing the Donor Pool: Quantifying the Potential Impact of a Portable Organ-Care System for Expanded Criteria Heart Donation	10
Transforming Ambulatory Heart Failure Care in the Coronavirus Disease-19 Era: Initial Experience From a Heart Failure Disease Management Clinic	10
Impact of Socioeconomic Status on Outcomes After Ventricular Assist Device Implantation Using the Area Deprivation Index	10
Safe Ambulation of Critically Ill Cardiac Patients With Femoral Balloon Pumps: A Case Cohort Study	10
Characterization of the Progression From Ambulatory to Hospitalized Heart Failure With Preserved Ejection Fraction	10
Epidemiology of Worsening Heart Failure in a Population-based Cohort from Alberta, Canada: Evaluating Eligibility for Treatment With Vericiguat	10
National Trends in the Use of Sacubitril/Valsartan	10
Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of A	10
Hemodynamic Aberrancies in Left Ventricular Assist Device–Associated Heart Failure Syndromes	10
Fluid REStriction in Heart Failure vs Liberal Fluid UPtake: Rationale and Design of the Randomized FRESH-UP Study	10
Chronic Intravenous Inotropic Support as Palliative Therapy and Bridge Therapy for Patients With Advanced Heart Failure: A Single-Center Experience	10
Soluble ST2 and Diuretic Efficiency in Acute Heart Failure and Concomitant Renal Dysfunction	10
Addendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2—Evidence Base and Standardized Methods of Imaging	10
The Effects of Inhaled Sodium Nitrite on Pulmonary Vascular Impedance in Patients With Pulmonary Hypertension Associated with Heart Failure With Preserved Ejection Fraction	10
Intra-aortic Balloon Pump for Acute-on-Chronic Heart Failure Complicated by Cardiogenic Shock	9
Resting Oxygen Consumption and Heart Failure: Importance of Measurement for Determination of Cardiac Output With the Use of the Fick Principle	9
Improved Outcomes in Severe Primary Graft Dysfunction After Heart Transplantation Following Donation After Circulatory Death Compared With Donation After Brain Death	9
Managing Heart Failure in Patients on Dialysis: State-of-the-Art Review	9
Direct Assessment of Muscle Sympathetic Nerve Activity During Exercise in Heart Failure With Preserved Ejection Fraction: A Case Report	9
The Intersection of Heart Failure and Critical Care: The Contemporary Cardiac Intensive Care Unit and the Opportunity for a Unique Training Pathway	9
Innovations in Heart Transplantation: A Review	9
Echocardiographic Evaluation of Left Ventricular Filling Pressure in Patients With Heart Failure With Preserved Ejection Fraction: Usefulness of Inferior Vena Cava Measurements and 2016 EACVI/ASE Reco	9
Epidemiology of Acute Heart Failure in Critically Ill Patients With COVID-19: An Analysis From the Critical Care Cardiology Trials Network	9
Ten-Year Risk-Prediction Equations for Incident Heart Failure Hospitalizations in Chronic Kidney Disease: Findings from the Chronic Renal Insufficiency Cohort Study and the Multi-Ethnic Study of Ather	9
Multinephron Segment Diuretic Therapy to Overcome Diuretic Resistance in Acute Heart Failure: A Single-Center Experience	9
Pulmonary Artery Pressure Monitoring during the COVID-19 Pandemic in New York City	9
Risk Prediction for Peripartum Cardiomyopathy in Delivering Mothers: A Validated Risk Model	9
Universal Definition and Classification of Heart Failure: Is It universal? Does It Define Heart Failure?	9
Subjective Financial Hardship due to Medical Bills Among Patients With Heart Failure in the United States: The 2014–2018 Medical Expenditure Panel Survey	9
Implementing Nonphysician Provider Guideline-Directed Medical Therapy Heart Failure Clinics: A Multi-National Imperative	9
Enhanced Recovery After Surgery in Patients Implanted with Left Ventricular Assist Device	9
Sex-Associated Differences in Cardiac Reverse Remodeling in Patients Supported by Contemporary Left Ventricular Assist Devices	9
Rationale, Design and Baseline Characteristics of the PARAGLIDE-HF Trial: Sacubitril/Valsartan vs Valsartan in HFmrEF and HFpEF With a Worsening Heart Failure Event	9
Clinical significance of reactive oxidative metabolites in patients with heart failure with reduced left ventricular ejection fraction	9
Prognostic Interplay Between COVID-19 and Heart Failure With Reduced Ejection Fraction	9
Sacubitril/Valsartan Improves Left Ventricular Function in Chronic Pressure Overload Independent of Intact Cyclic Guanosine Monophosphate-dependent Protein Kinase I Alpha Signaling	9
Left Atrial Stiffness Index Independently Predicts Exercise Intolerance and Quality of Life in Older, Obese Patients With Heart Failure With Preserved Ejection Fraction	9
Phosphodiesterase-5 Inhibitors and Outcomes During Left Ventricular Assist Device Support: A Systematic Review and Meta-Analysis	9
Pretransplant Right Ventricular Dysfunction Is Associated With Increased Mortality After Heart Transplantation: A Hard Inheritance to Overcome	9
Safety Indicators in Patients Receiving High-intensity Care After Hospital Admission for Acute Heart Failure: The STRONG-HF Trial	8
Prior Carpal Tunnel Syndrome and Early Concomitant Echocardiographic Findings Among Patients With Cardiac Amyloidosis	8
Effects of Angiotensin-Neprilysin Inhibition in Canines with Experimentally Induced Cardiorenal Syndrome	8
Acute Acalculous Cholecystitis in a Patient With COVID-19 and a LVAD	8
Prognostic Role of Cardiopulmonary Exercise Testing in Wild-Type Transthyretin Amyloid Cardiomyopathy Patients Treated With Tafamidis	8
Predictors of Change in Left-Ventricular Structure and Function in a Trial of Extended Hours Hemodialysis	8
Fibroblast Growth Factor 23 and Exercise Capacity in Heart Failure with Preserved Ejection Fraction	8
Myeloperoxidase Inhibition in Heart Failure With Preserved or Mildly Reduced Ejection Fraction: SATELLITE Trial Results	8
Longitudinal Changes in Circulating Ketone Body Levels in Patients With Acute Heart Failure: A Post Hoc Analysis of the EMPA-Response-AHF Trial	8
The Cost-Effectiveness of Palliative Care: Insights from the PAL-HF Trial	8
Hepatocyte Growth Factor and Incident Heart Failure Subtypes: The Multi-Ethnic Study of Atherosclerosis (MESA)	8
Active B-Type Natriuretic Peptide Measured by Mass Spectrometry and Response to Sacubitril/Valsartan	8
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Of Amg 986, a Novel Small Molecule Apelin Receptor Agonist, in Healthy Subjects and Heart Failure Patients	8
Effect of Empagliflozin Versus Placebo on Body Fluid Balance in Patients With Acute Myocardial Infarction and Type 2 Diabetes Mellitus: Subgroup Analysis of the EMBODY Trial	8
Association of Reduced Hospitalizations and Mortality Rates Among COVID-19-Vaccinated Patients With Heart Failure	8
Cardiac Xenotransplantation: Rebirth Amidst an Uncertain Future	8
Hand Grip Strength Predicts Mortality and Quality of Life in Heart Failure: Insights From the Singapore Cohort of Patients With Advanced Heart Failure	8
Continuous Infusion Versus Intermittent Boluses of Furosemide in Acute Heart Failure: A Systematic Review and Meta-Analysis	8
A First in Human Multi-center, Open Label, Prospective Study to Evaluate Safety, Usability and Performance of the VisONE System for Heart Failure with a Reduced Left Ventricular Ejection Fraction	7
Palliative Inotropes in Advanced Heart Failure: Comparing Outcomes Between Milrinone and Dobutamine	7
Combination Biomarkers for Risk Stratification in Patients With Chronic Heart Failure Biomarkers Prognostication in HF	7
A Randomized Controlled Trial of Mobile Health Intervention in Patients With Heart Failure and Diabetes	7
Prescription Filling Patterns of Evidence-Based Medical Therapies for Heart Failure During the COVID-19 Pandemic in the United States	7
Combining Iron Supplements With SGLT2 Inhibitor-Stimulated Erythropoiesis in Heart Failure: Should We Be Worried About Thromboembolic Events?	7
Pregnancy With a Ventricular Assist Device: A Systematic Review of the Existing Literature	7
Exploring Physician Perceptions of the 2018 United States Heart Transplant Allocation System	7
Elevated AT1R Antibody and Morbidity in Patients Bridged to Heart Transplant Using Continuous Flow Left Ventricular Assist Devices	7
Relationships Between Objectively Measured Physical Activity, Exercise Capacity, and Quality of Life in Older Patients With Obese Heart Failure and Preserved Ejection Fraction	7
Making the Case for an Expanded Indication for Sacubitril/Valsartan in Heart Failure	7
The Additive Prognostic Value of Serial Plasma Interleukin-6 Levels over Changes in Brain Natriuretic Peptide in Patients with Acute Heart Failure	7
In-Hospital Serum Uric Acid Change Predicts Adverse Outcome in Patients With Heart Failure	7
Palliative Care Services in Patients Admitted With Cardiogenic Shock in the United States: Frequency and Predictors of 30-Day Readmission	7
Prescriptions for Potentially Inappropriate Medications from the Beers Criteria Among Older Adults Hospitalized for Heart Failure	7
Medical Treatment of Heart Failure: Ignore the Ejection Fraction and Treat All?	7
Contemplation from Our Hearts: A Call to Shift From Failure to Function	7
Predictors of Physical Capacity 6 Months After Implantation of a Full Magnetically Levitated Left Ventricular Assist Device: An Analysis From the ELEVATE Registry	7
Annexin A1 is a Potential Novel Biomarker of Congestion in Acute Heart Failure	7
Sex and Race Differences in Cardiac Sarcoidosis Presentation, Treatment and Outcomes	7
Left Ventricular Assist Device Caregiver Experiences and Health Outcomes: A Systematic Review of Qualitative and Quantitative Studies	7
An Interprofessional Collaborative Practice Can Reduce Heart Failure Hospital Readmissions and Costs in an Underserved Population	7
Clinical Outcome Predictions for the VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) Trial	7
Exposure to Elevated Nitrogen Dioxide Concentrations and Cardiac Remodeling in Patients With Dilated Cardiomyopathy	7
Social Determinants of Health and Rates of Implantation for Patients Considering Destination Therapy Left Ventricular Assist Device	7
Role of Internal Jugular Venous Ultrasound in suspected or confirmed Heart Failure: A Systematic Review	7
Cardiovascular Death Risk in Recovered Mid-Range Ejection Fraction Heart Failure: Insights From Cardiopulmonary Exercise Test	7
Soluble Urokinase Plasminogen Activator Receptor Levels and Outcomes in Patients with Heart Failure	7
Outpatient Intravenous Diuretic Therapy for Acute Heart Failure: A Simplified Solution to a Formidable Problem	7
Safety of Contemporary Heart Failure Therapy in Patients with Continuous-Flow Left Ventricular Assist Devices	7
Predicting Long-Term Mortality in Patients With Acute Heart Failure by Using Machine Learning	7
Non-Concordance between Patient and Clinician Estimates of Prognosis in Advanced Heart Failure	7